University of Copenhagen-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

2022

  1. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 11, pp. 1541-1548

2019

  1. Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort

    Annals of the Rheumatic Diseases

  2. Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 634-640

  3. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen

    Rheumatology (United Kingdom), Vol. 58, Núm. 7, pp. 1259-1267

2016

  1. Off-label use of rituximab for systemic lupus erythematosus in Europe

    Lupus Science and Medicine, Vol. 3, Núm. 1

2013

  1. Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients

    ARTHRITIS AND RHEUMATISM

2012

  1. Lymphoma Risk in Systemic Lupus: Effects of Disease Activity Versus Treatment

    ARTHRITIS AND RHEUMATISM

2011

  1. Biologics use in SLE in 23 Centers - Data from the International Registry for Biologics In SLE (IRBIS)

    ARTHRITIS AND RHEUMATISM